Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Charles Doillon

Formation
B.Sc. (1970) Biologie humaine, Université Claude Bernard, France

M.Sc. (1981) Physiologie-Immunologie, Université Claude Bernard, France

Ph.D. (1993) Génie biomedical, Université Claude Bernard, France

M.D. (1981) Chirurgie/Cicatrisation, Université Claude Bernard, France

Post-MD (1982-83) Wound Healing, Shriners Burn Institute, Massachusetts General Hospital, USA

Post-doctorat/Chercheur boursier (1983-1988) UMDNJ-Robert Wood Johnson Medical School, USA

Aucune offre active

Autres opportunités de carrière
Axe principal
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
T-2-50
Québec (Québec)
CANADA G1V 4G2

Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
T-2-53
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 48678
Télécopieur(s)
+1 418-654-2298
Courriel(s)
charles.doillon@crchudequebec.ulaval.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Wang XQ, Aka JA, Li T, Xu D, Doillon CJ, Lin SX. Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78. The Journal of steroid biochemistry and molecular biology,  2017. Epub
Cote MF, Turcotte A, Doillon C, Gobeil S. Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation. Journal of visualized experiments : JoVE,  2016.  
Rakhila H, Al-Akoum M, Doillon C, Lacroix-Pepin N, Leboeuf M, Lemyre M, Akoum A, Pouliot M. Augmented Angiogenic Factors Expression via FP Signaling Pathways in Peritoneal Endometriosis. The Journal of clinical endocrinology and metabolism,  2016. 101: 4752-4763
Wang X, Gerard C, Theriault JF, Poirier D, Doillon CJ, Lin SX. Synergistic control of sex hormones by 17beta-HSD type 7: a novel target for estrogen-dependent breast cancer. Journal of molecular cell biology,  2015. 7: 568-79
Marelli B, Le Nihouannen D, Hacking SA, Tran S, Li J, Murshed M, Doillon CJ, Ghezzi CE, Zhang YL, Nazhat SN, Barralet JE. Newly identified interfibrillar collagen crosslinking suppresses cell proliferation and remodelling. Biomaterials,  2015. 54: 126-35
Wang X, Sang X, Diorio C, Lin SX, Doillon CJ. In vitro interactions between mammary fibroblasts (Hs 578Bst) and cancer epithelial cells (MCF-7) modulate aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases. Molecular and cellular endocrinology,  2015. 412: 339-48
Florianova L, Orain M, Tetu B, Doillon C. Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease. Biotechnic & histochemistry : official publication of the Biological Stain Commission,  2013. 88: 222-34
Mohebbi-Kalhori D, Behzadmehr A, Doillon CJ, Hadjizadeh A. Computational modeling of adherent cell growth in a hollow-fiber membrane bioreactor for large-scale 3-D bone tissue engineering. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs,  2012. 15: 250-65
Jegham H, Maltais R, Roy J, Doillon C, Poirier D. Biological evaluation of a new family of aminosteroids that display a selective toxicity for various malignant cell lines. Anti-cancer drugs,  2012. 23: 803-14
Abbasi M, Aliabadi HM, Moase EH, Lavasanifar A, Kaur K, Lai R, Doillon C, Uludag H. siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice. Pharmaceutical research,  2011. 28: 2516-29
© 2017 Tous droits réservés Centre de recherche du CHU de Québec